Wellness Firm The Better Being Co. Launches US$213 Million IPO

Whole-body wellness enterprise The Better Being Co. announced today the launch of its initial public offering, seeking to raise as much as US$212.5 million. The company is slated to publicly trade on the New York Stock Exchange under the symbol “BBCO”.

The offering will be conducted through the issuance of 12,500,000 common shares with an expected offering price between US$15.00 and US$17.00 per share.

The company also plans to grant the underwriters a 30-day over-allotment option to purchase additional 1,875,000 common shares from its principal stockholders at the same IPO price. Goldman Sachs & Co., Credit Suisse Securities (USA), and Jefferies LLC are all acting as lead underwriters for the said offering.

The Utah-based enterprise is currently conducting business as Nutraceutical International and plans to change its name to The Better Being Co. prior to the IPO. The company was previously listed publicly until it was taken private by equity firm HGGC in a US$446 million acquisition deal.

The Better Being Co. reported US$344 million in sales for the fiscal year ending March 31, 2021.


Information for this briefing was found via Sedar and The Better Being Co. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why $50 Silver, $4000 Gold Might Be Closer Than Anyone Thinks | Bradley Langille – GoGold Resources

Why Silver’s True Price Could Be Much Higher | Joaquín Marias – Argenta Silver

Gold Enters A ‘Stronger For Longer’ Phase | Richard Young – i-80 Gold

Recommended

Emerita Resources Intersects Further Mineralization At El Cura, Expanding Deposit

ESGold Sees ANT Survey Reveal Vertically Continuous System To 1,200 Metres Depth

Related News

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM

Radiation Oncology Firm Shuttle Pharmaceuticals Prices US$10 Million IPO

Pharmaceutical company focused on radiation therapy treatment Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) started trading...

Thursday, September 1, 2022, 02:21:00 PM

Biotech Firm PepGen Prices US$108 Million IPO

Biopharmaceutical company PepGen, Inc. (Nasdaq: PEPG) began trading on the Nasdaq Global Select Market on...

Monday, May 9, 2022, 02:27:00 PM

Birkenstock Files For $8 Billion IPO

Birkenstock, the renowned German footwear company, took a significant step towards going public on Tuesday....

Wednesday, September 13, 2023, 10:36:00 AM

Asia-Focused Biotech SPAC Valuence Merger I Prices US$200 Million IPO

Special purpose acquisition company Valuence Merger Corp. I (Nasdaq: VMCAU) started trading on the Nasdaq...

Tuesday, March 1, 2022, 02:26:00 PM